A novel multifunctional anti-PD-L1-CD16a-IL15 induces potent cancer cell killing in PD-L1-positive tumour cells

Cancer is the most acute disease and the leading cause of patient death worldwide. Both chemotherapy and molecular-based therapies play an important role in curing cancer. However, the median and overall survival of patients is poor. To date, immune therapies have changed the treatment methods for c...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yumei, Wu, Lingjun, Liu, Yueying, Ma, Siwen, Huang, Biyi, Feng, Xianjing, Wang, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136603/
https://www.ncbi.nlm.nih.gov/pubmed/35477065
http://dx.doi.org/10.1016/j.tranon.2022.101424

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136603/
https://www.ncbi.nlm.nih.gov/pubmed/35477065
http://dx.doi.org/10.1016/j.tranon.2022.101424

Ejemplares similares